S&P revises Boston Scientific outlook to negative on franchise pressures
Our full article on this story is being written.
This page updates by itself in about a minute – you can also keep reading the summary below.
This page updates by itself in about a minute – you can also keep reading the summary below.
What we know so far
Risk warning: This article is for information only and is not investment advice. Trading forex, CFDs, stocks and crypto carries a high risk of losing money. Prices move fast – check live quotes before you trade.
